Skip to main content
Premium Trial:

Request an Annual Quote

EMBL, Belgium s SARS Center Create Research Partnership

NEW YORK, June 19 - The European Molecular Biology Laboratory and the Belgium-based Sars International Center will collaborate on certain scientific research, including genomic, molecular, and cellular research.


A "major goal" of the agreement, called the Partnership in Marine Molecular Biology, is to "facilitate scientific exchange and collaborations." The groups will organize joint scientific meetings "to exchange information on current projects, stimulate in a bottom-up manner future collaborations and personnel exchange between the two institutions and others, and thus assemble a scientific community of critical mass interested in marine molecular biology," according to the partners. The institutes will also support joint funding applications.

The institutes will also provide access to each other's facilities, databases, and instrumentation for visiting scientists. These include the marine biology infrastructures in Bergen, Norway, where the Sars center has its headquarters, and the EMBL's facilities for genomics, proteomics, functional genomic, and advanced light microscopy facilities in Heidelberg, Germany.

The Sars Center will establish an International PhD Program in marine molecular biology. Students will receive research training at the Sars Center, while the University of Bergen, the EMBL, and "other international institutes" will plan the program's theoretical and practical course work.

An agreement for joint PhD degrees from the University of Bergen and EMBL is "currently being negotiated" and will join the partnerships that EMBL has with universities throughout its member states.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.